ITNS Stock UPDATES Itonis Inc (ITNS) 0.0143 09/15/2014 21:27

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Itonis Inc (ITNS) 0.0143 $ITNS

Itonis Pharmaceuticals Announces First Emesyl(R) Manufacturer Production Release Date
Marketwire - Tue Aug 12, 7:31AM CDT
Itonis, Inc. (PINKSHEETS: ITNS)

Itonis Pharmaceuticals Authorizes Start of Emesyl(R) Inaugural Production Run
Marketwire - Wed Jun 25, 7:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) Itonis is pleased to announce that, with the finalization of its new packaging design and product labeling, it has given the go ahead to Oasis Health Products to produce 16,000 units of its Emesyl(R) homeopathic product. Itonis has pre-paid necessary funds to Oasis to commence the inaugural production run.

Itonis Pharmaceuticals Completes Final Package Design, Enabling Start of Emesyl(R) Production
Marketwire - Thu Jun 19, 9:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that the final product packaging and bottle label designs for its Emesyl(R) over-the-counter homeopathic product for nausea relief are now complete. The finalized packaging design includes the 800 product phone number, the product information website, the product UPC code, and a brand new visual look that is very appealing to consumers. New pictures of the final box and bottle designs can be found on the company's website news tab at # http://www.itonisholdings.com/news.

COREwafer Industries Inc.'s Stock Volume Soars amid Lawsuits and Hidden Debt
ACCESSWIRE - Tue Apr 01, 9:02AM CDT
COREwafer Industries Inc.'s (OCTPINK: WAFR) share volume soared Mar. 31, with 92,841,276 shares changing hands, nearly double its three-month average volume of 47,097,800 shares.

Itonis, Inc. Joins the National Cannabis Industry Association to Advance Into the Medical Marijuana Products and Services Sector
Marketwire - Tue Apr 01, 8:03AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has joined the National Cannabis Industry Association (NCIA) as a member in a part of the Company's preparations to expand into the medical marijuana products and services sector. The Company is positioning itself for tremendous opportunities in this vibrant sector in unison with its recent app licensing agreement with MyECheck, Inc.

Itonis Inc. Signs Licensing Agreement with MyECheck Inc. for Medical Marijuana Point of Purchase App
ACCESSWIRE - Tue Apr 01, 12:45AM CDT
Itonis Inc. (OTC: ITNS) has signed a Licensing Agreement with MyECheck, Inc. that opens the gates for Itonis to possibly become a leading player in the blossoming medical marijuana industry. In the licensing agreement, Itonis will acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license. The company believes there is a significant revenue opportunity in addressing the demand regarding medical marijuana and the point of sales from medical suppliers.

Itonis, Inc. OTCpink ITNS today announced that it has signed a Licensing Agreement with MyECheck,OTCpink MYEC
M2 - Fri Mar 28, 12:50PM CDT
March 28, 2014 Vancouver (321gostocks) -- Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.

Itonis, Inc. Signs App License Agreement With MyECheck, Inc. for Medical Marijuana Point of Purchase App
Marketwire - Fri Mar 28, 10:14AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today announced that it has signed a Licensing Agreement with MyECheck, Inc. for Itonis to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales. There is no expiration date on that license.

Itonis, Inc. Update on Company Direction With Emesyl and Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Wed Mar 26, 10:29AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) today issued the following update to its shareholders:

Arotech Corporation Announces More than $2M in Orders; DirectView Holdings Plans to Open a Colorado Office
ACCESSWIRE - Tue Mar 25, 11:26PM CDT
Arotech Corporation (NASDAQ: ARTX) - For an in-depth report on Arotech Corporation follow: www.BullTrends.com/stockquote/ARTX

Itonis Pharmaceuticals Completed Evaluation of Emesyl Product to Take Next Step to Manufacturing
Marketwire - Wed Mar 19, 10:00AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that Charles Hensley, PhD., the inventor of the Zicam(R) cold remedy, and his team has completed their evaluation of the manufactured samples of Emesyl(TM), the company's over-the-counter homeopathic product for nausea relief.

Itonis, Inc. Signs LOI With MyECheck, Inc. for Licensing of App for Medical Marijuana Point of Purchase
Marketwire - Mon Mar 17, 2:29PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has entered into a Letter of Intent with MyECheck, Inc. to acquire a software license for MyECheck's patented mobile payment app that will facilitate point of purchase transactions for medical marijuana, gambling, and general retail sales.

Itonis Pharmaceuticals Received Emesyl Samples for Evaluation
Marketwire - Fri Feb 28, 12:50PM CST
Itonis, Inc. (PINKSHEETS: ITNS) is pleased to announce that it has received and is currently evaluating samples of its Emesyl(TM) product from its manufacturer. Oasis Health Products, Inc. delivered two versions of the Emesyl(TM) anti-nausea formula which are currently being evaluating for tolerance.

Itonis Pharmaceuticals and Charles Hensley, Ph.D. to Begin Distributing Emesyl(TM) Anti-Nausea Homeopathic Product in Mexico
Marketwire - Thu Sep 12, 7:30AM CDT
Itonis, Inc.'s pharmaceutical division (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, are pleased to announce that Hensley Brothers Distribution, LLC ("HBD" will distribute Emesyl((TM)), the Company's over-the-counter homeopathic product for nausea relief, to Mexico through one of HBD's distribution partners.

Itonis Pharmaceuticals, Led by Dr. Charles Hensley, the Inventor of Zicam(R) Cold Remedy, Received FDA Labeler Status
Marketwire - Wed Jul 31, 8:02AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company has received its labeler's code from the federal Food and Drug Administration (FDA).

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Distribute Homeopathic Products in Retail Chains
Marketwire - Fri Jul 19, 8:45AM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce that the Company's line of homeopathic products will be distributed nationally and internationally by Hensley Brothers Distribution, LLC.

Charles Hensley, Ph.D., Inventor of Zicam(R) Cold Remedy, and Itonis Pharmaceuticals to Obtain FDA Labeler Status
Marketwire - Tue Jun 25, 1:30PM CDT
Itonis, Inc. (PINKSHEETS: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) cold remedy, are pleased to announce the Company has commenced the application process to file with the U.S. Food and Drug Administration as a labeler.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy, And Itonis Pharmaceuticals Prepared to File for the National Drug Code Number for the Emesyl(tm) Anti-Nausea Products to Launch Sales in Fall 2013
GlobeNewswire - Fri May 31, 8:30AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the Company is prepared to file for the National Drug Code (NDC) number for their over-the-counter Emesyl(TM) homeopathic product.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals to Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 11:53AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.

Charles Hensley, Ph.D., Inventor of Zicam(r) Cold Remedy And Itonis Pharmaceuticals Finalized Product Packaging For The Emesyl Anti-Nausea Products
GlobeNewswire - Thu May 30, 10:00AM CDT
Itonis, Inc. (OTC: ITNS) and Charles Hensley, Ph.D., the inventor of the Zicam(R) Cold Remedy, and founding member of Itonis Pharmaceuticals, are pleased to announce the finalization of the packaging graphics for their over-the-counter homeopathic product EmesylTM which can be viewed at the Company's website at www.itonisholdings.com.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Lennar Lawsuit Puts Land-Light Claims Under a Microscope

Updated Category News Views 118

Three ugly selloffs, a murky land-bank story, and a fresh securities complaint have turned Lennar into the sort of holding that makes shareholders reread every footnote. The lawsuit is not a verdict, and the allegations remain unproven, but the timeline is nasty enough that investors in NYSE:LEN should not shrug it off as ordinary housing-cycle turbulence. The Dates...

Continue Reading
V2’s FOAS Bets on Candid Ad Sales Operator Dialogue

Updated Category News Views 180

Ad sales rarely gets fixed by another ballroom panel, and V2 seems to know it. Its new Future of Ad Sales, or FOAS, forum is built around a simpler premise: put senior operators in a small room, keep vendors and conference theatrics out of the way, and let people compare the ugly real-world details of running revenue machines. Announced November 19, 2026, FOAS is an...

Continue Reading
Vail Resorts Bets on Music to Deepen Epic Pass Demand

Updated Category News Views 119

A bass drop at 11,000 feet is not merely a party trick when you run 42 mountain resorts. Vail Resorts is putting live music, après programming and destination events squarely beside skiing and riding for winter 2026-27, and the business logic is pretty plain: give people another reason to buy early, stay longer and return with friends. For investors watching MTN, this is...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
Huhtamaki Maps Its 2027 Reporting Dates for Investors

Updated Category News Views 17

A calendar release rarely makes the pulse race, but it tells shareholders when the curtain will actually go up. Huhtamäki Oyj has laid out its 2027 financial reporting timetable, and the useful part is its plainness: investors now know the handful of dates when management will have to put numbers, not broad ambitions, in front of the market. For a packaging company, that...

Continue Reading
Siteimprove Turns Accessibility Checks Into Agent Spend

Updated Category News Views 153

Accessibility work has usually been the thing teams promise to fix after the launch party is over. Siteimprove is trying to shove that discipline directly into the AI-agent workflow, announcing on November 19, 2026 that its Siteimprove.ai Accessibility Agent is available through Agentic Commerce on AWS Marketplace. The practical hook is simple enough: an AI agent can...

Continue Reading
Hard Rock Tampa Bets $30 Million on Smoke-Free Play

Updated Category News Views 71

Cigarette smoke is getting treated like a revenue problem in Tampa, and that is a far more interesting signal than another ribbon-cutting photo. Seminole Hard Rock Hotel & Casino Tampa opened The Breeze: A Smoke-Free Experience by Hard Rock on Nov. 19, 2026, following a $30 million transformation aimed at guests who want clean-air casino time from arrival through...

Continue Reading
Colossal's Halloween Campaign Wins Top Communicator Honor

Updated Category News Views 76

A horror-themed fan competition putting money toward hospitalized children is not the usual awards-season material, which is precisely why Colossal's latest recognition lands with some weight. The Phoenix-based professional fundraiser received an Award of Excellence, the top honor at the 32nd annual Communicator Awards, for its Face of Halloween campaign in the Innovation...

Continue Reading
Makera A1S Tests the Desktop CNC Metal-Cutting Promise

Updated Category News Views 84

Aluminum chips are where desktop-machine marketing stops bluffing, and Makera is leaning right into that test with the A1S. The company opened global pre-orders on November 18 for a machine aimed squarely at the awkward middle ground: users who have outgrown entry-level hobby gear but do not have room, budget, or patience for a full industrial setup. That is a real market...

Continue Reading
Genome-Written XDP Mice Could Sharpen Drug Research

Updated Category News Views 88

Seventy-eight thousand DNA letters changed the pace of a cruel little-known disease story. NYU Langone researchers inserted a human disease-linked stretch of genetic material into mice and produced an accelerated model of X-linked dystonia-parkinsonism, or XDP. That is a serious laboratory accomplishment, not a cure announcement, and it deserves to be read with both...

Continue Reading

Top 5 Most Recently Viewed Articles

Canada Nickel Secures EDC Interest for $500 Million Financing

Updated Category News Views 137

Canada Nickel's Significant Financing Achievement Canada Nickel Company Inc. is excited to share a major milestone in its efforts to secure financing for the Crawford Nickel Sulphide Project. The company has received a Letter of Interest (LOI) from Export Development Canada (EDC), indicating its intention to offer up to US$500 million in long-term debt financing for the...

Continue Reading
BlackRock Expands Offerings with New ETF Share Class Approval

Updated Category News Views 202

BlackRock Pursues SEC Approval for ETF Share Classes BlackRock Inc (NYSE: BLK) is making headlines as it has formally applied to the U.S. Securities and Exchange Commission (SEC) for a ruling that would allow the establishment of exchange-traded fund (ETF) share classes linked to its existing mutual funds. This significant move positions BlackRock as the largest firm...

Continue Reading
Profusa Unveils Innovative AI Portal for Continuous Biochemistry Monitoring

Updated Category News Views 133

Profusa Introduces AI-Powered Insight Portal for Biomarker Monitoring Profusa, a pioneering company in digital health technology, is transforming how healthcare providers monitor patient biochemistry through an innovative AI-driven insight portal. This advanced portal will enhance continuous biomarker tracking, utilizing cutting-edge technology to provide clinical...

Continue Reading
Investigation Launch for Pliant Therapeutics Investors: What to Know

Updated Category News Views 192

Investigation of Pliant Therapeutics, Inc. Pliant Therapeutics, Inc. (NASDAQ: PLRX) is currently under scrutiny as investors seek clarity on potential securities law violations. This investigation presents an opportunity for shareholders who believe they have been misled regarding their investments. Shareholders are encouraged to come forward to ensure their rights are...

Continue Reading
Fish Window Cleaning's New Headquarters: A Step Forward in Growth

Updated Category News Views 2161

Fish Window Cleaning Unveils New Corporate Headquarters Fish Window Cleaning Services is excited to announce the grand opening of its brand-new corporate headquarters, a facility that signifies an important milestone in its growth and operational capabilities. Located at 217 Chesterfield Towne Centre, this expansive 12,500-square-foot space is intended to serve as the...

Continue Reading